A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy

Condition:   Cardiomyopathy, Hypertrophic Obstructive Interventions:   Drug: CT-20;   Drug: Placebo Sponsor:   Celltrion Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials